Literature DB >> 21536159

Epidemiology, assessment, and treatment of dementia.

Milap A Nowrangi1, Vani Rao, Constantine G Lyketsos.   

Abstract

The risk of developing dementia is associated with increasing age, lifestyle, and cardiovascular health. Alzheimer dementia is characterized by progressive cognitive deficits and decline in functional ability. Using history, examination, and laboratory testing, the clinician can evaluate the patient with dementia. Specific to these conditions are assessments of cognition, neuropsychiatric symptoms, and level of functioning. Managing neuropsychiatric symptoms is challenging and requires a team approach in which nonpharmacological strategies are preferred before medications are considered. Various diagnostic methods are being developed to discriminate disease from nondisease and track progression. Drug discovery is identifying novel molecules that target underlying disease mechanisms.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21536159     DOI: 10.1016/j.psc.2011.02.004

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  20 in total

1.  [Implementation of the German S3 guidelines on dementia in clinical practice: wish or reality?]

Authors:  H Lohmann; F Kulessa; H Holling; A Johnen; S Reul; G Lueg; T Duning
Journal:  Nervenarzt       Date:  2017-08       Impact factor: 1.214

2.  Trends in Drug Prescription Rates for Dementia: An Observational Population-Based Study in France, 2006-2014.

Authors:  Mathilde François; Jonathan Sicsic; Alexis Elbaz; Nathalie Pelletier Fleury
Journal:  Drugs Aging       Date:  2017-09       Impact factor: 3.923

3.  Subtle changes in daily functioning predict conversion from normal to mild cognitive impairment or dementia: an analysis of the NACC database.

Authors:  Milap A Nowrangi; Paul B Rosenberg; Jeannie-Marie S Leoutsakos
Journal:  Int Psychogeriatr       Date:  2016-08-08       Impact factor: 3.878

Review 4.  Psychosocial interventions for late-life major depression: evidence-based treatments, predictors of treatment outcomes, and moderators of treatment effects.

Authors:  Dimitris N Kiosses; Andrew C Leon; Patricia A Areán
Journal:  Psychiatr Clin North Am       Date:  2011-06

5.  Challenging Assumptions About African American Participation in Alzheimer Disease Trials.

Authors:  Richard E Kennedy; Gary R Cutter; Guoqiao Wang; Lon S Schneider
Journal:  Am J Geriatr Psychiatry       Date:  2017-04-25       Impact factor: 4.105

Review 6.  Epigenetic determinants of healthy and diseased brain aging and cognition.

Authors:  Schahram Akbarian; Michal Schnaider Beeri; Vahram Haroutunian
Journal:  JAMA Neurol       Date:  2013-06       Impact factor: 18.302

Review 7.  Suicide in older adults: the role of emotions and cognition.

Authors:  Dimitris N Kiosses; Katalin Szanto; George S Alexopoulos
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

8.  Effect of music intervention on the cognitive and depression status of senior apartment residents in Taiwan.

Authors:  Shu-Yu Tai; Ling-Chun Wang; Yuan-Han Yang
Journal:  Neuropsychiatr Dis Treat       Date:  2015-06-12       Impact factor: 2.570

9.  Personal Strengths and Health Related Quality of Life in Dementia Caregivers from Latin America.

Authors:  Stephen K Trapp; Paul B Perrin; Richa Aggarwal; Silvina Victoria Peralta; Miriam E Stolfi; Eliana Morelli; Leticia Aracely Peña Obeso; Juan Carlos Arango-Lasprilla
Journal:  Behav Neurol       Date:  2015-06-16       Impact factor: 3.342

Review 10.  Principles and management of neuropsychiatric symptoms in Alzheimer's dementia.

Authors:  Milap A Nowrangi; Constantine G Lyketsos; Paul B Rosenberg
Journal:  Alzheimers Res Ther       Date:  2015-01-29       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.